Bio-barcodes based on oligonucleotide-modified nanoparticles

• US 6,974,669 B2
• Filed: 03/27/2002
• Issued: 12/13/2005
• Est. Priority Date: 03/28/2000
• Status: Expired due to Term

• Current Assignee: Northwestern University
• Original Assignee: Nanosphere Incorporated (DiaSorin S.p.A.)
• Inventors: Park, So-Jung, Mirkin, Chad A., Nam, Jwa-Min
• Primary Examiner(s): Riley, Jezia
• Application Number:
  US10/108,211
• Publication Number:
  US 20020192687A1
• Time in Patent Office: 1,357 Days
• Field of Search: 435/5, 435/6, 435/7.1, 435/7.2, 536/23.1, 536/24.3
• US Class Current: 435/6.11
• CPC Class Codes: B01J 2219/00274 Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
• CPC Class Codes: B82Y 30/00 Nanotechnology for materials or surface science, e.g. nanocomposites
• CPC Class Codes: C07B 2200/11 Compounds covalently bound to a solid support
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6816 characterised by the detection means C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6825 Nucleic acid detection involving sensors
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/6834 Enzymatic or biochemical coupling of nucleic acids to a solid phase
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence
• CPC Class Codes: C12Q 2525/197 incorporating a spacer/coupling moiety
• CPC Class Codes: C12Q 2563/155 Particles of a defined size, e.g. nanoparticles
• CPC Class Codes: C12Q 2563/185 Nucleic acid dedicated to use as a hidden marker/bar code, e.g. inclusion of nucleic acids to mark art objects or animals
• CPC Class Codes: C40B 40/00 Libraries per se, e.g. arrays, mixtures
• CPC Class Codes: Y10S 977/924 using nanostructure as support of dna analysis

Abstract

The present invention relates to a screening methods, compositions, and kits for detecting for the presence or absence of one or more target analytes, e.g. proteins such as antibodies, in a sample. In particular, the present invention relates to a method that utilizes reporter oligonucleotides as biochemical barcodes for detecting multiple protein structures or other target analytes in one solution.

Claims

1. A method for detecting for the presence or absence of a target analyte in a sample comprising:

providing a particle complex probe comprising a particle having oligonucleotides bound thereto, a DNA barcode, and a oligonucleotide having bound thereto a specific binding complement to a target analyte, wherein the DNA barcode has a sequence having at least two portions, at least some of the oligonucleotides attached to the particle have a sequence that is complementary to a first portion of a DNA barcode, the oligonucleotides having bound thereto a specific binding complement have a sequence that is complementary to a second portion of a DNA barcode, and wherein the DNA barcode is hybridized at least to some of the oligonucleotides attached to the particle and to the oligonucleotides having bound thereto the specific binding complement;

contacting the sample with a particle complex probe under conditions effective to allow specific binding interactions between the analyte and the particle complex probe and form an aggregated complex in the presence of the analyte;

isolating the aggregated complex and subjecting the aggregated complex to conditions effective to dehybridize the aggregated complex and to release the DNA barcode;

isolating the DNA barcode; and

detecting for the presence of DNA barcode, wherein the presence of the DNA barcode is indicative of the presence of the target analyte in the sample.

5. The method of any one of claims 1, 2, 3 or 4 wherein the particles are nanoparticles.

6. The method of any one of claims 1, 2, 3 or 4 wherein the particles are metal, semiconductor, insulator, or magnetic nanoparticles.

7. The method of any one of claims 1, 2, 3 or 4 wherein the particles are gold nanoparticles.

8. The method according to any one of claims 1, 2, 3 or 4 wherein the isolated DNA barcodes are captured prior to detection using a substrate having oligonucleotides attached thereto, the oligonucleotides attached to the substrate having a sequence complementary to the sequence of a portion of the DNA barcode.

9. The method according to claim 8, wherein the substrate having plurality of types of oligonucleotides attached thereto in an array to allow for the detection of multiple portions of a single type of DNA barcode, the detection of multiple different DNA barcodes, or both.

10. The method according to any one of claims 1, 2, 3 or 4, wherein the isolated DNA barcodes are captured and detected by steps comprising:

providing a substrate having plurality of types of oligonucleotides attached thereto in an array to allow for the detection of multiple portions of a single type of DNA barcode, the detection of multiple different DNA barcodes, or both;

providing nanoparticles having oligonucleotides bound thereto, wherein a portion of the oligonucleotides bound to the nanoparticles have a sequence that is complementary to a portion of a DNA barcode;

contacting the isolated DNA barcodes with the substrate and the nanoparticles under conditions effective for hybridization of at least a first portion of the DNA barcodes with a complementary oligonucleotide bound to the substrate and a second portion of the DNA barcodes with some of the oligonucleotides bound to the nanoparticles; and

observing a detectable change.

11. The method according to claim 10 wherein the detectable change is the formation of dark areas on the substrate.

12. The method according to claim 10 wherein the detectable change is observed with an optical scanner.

13. The method according to claim 10 wherein the substrate is contacted with silver stain to produce the detectable change.

14. The method according to claim 10 wherein the DNA barcodes are contacted with the substrate so that the DNA barcodes hybridizes with complementary oligonucleotides bound to the substrate and then the DNA barcodes bound to the substrate is contacted with the nanoparticles having oligonucleotides bound thereto so that at least some of the oligonucleotides bound to the nanoparticles hybridize with a portion of the sequence of the DNA barcodes on the substrate.

15. The method according to claim 10 wherein the DNA barcodes are contacted with the nanoparticles having oligonucleotides bound thereto so that at least some of the oligonucleotides bound to the nanoparticles hybridize with a portion of the sequence of the DNA barcodes;

and contacting the DNA barcodes bound to the nanoparticles with the substrate so that a portion of the sequence of the DNA barcodes bound to the nanoparticles hybridizes with complementary oligonucleotides bound to the substrate.

16. The method of any one of claims 1, 2, 3 or 4 wherein the target analyte and the specific binding complement are members of a specific binding pair.

17. The method of claim 16 wherein the specific bind pairs comprise a ligand and receptor.

18. The method of claim 16 wherein the specific bind pair comprises antibody-antigen or polynucleotide pairs.

19. The method of any one of claims 1, 2, 3 or 4 wherein the target analyte is a monovalent or polyvalent ligand.

20. The method of any one of claims 1, 2, 3 or 4 wherein the DNA biobarcode is a reporter oligonucleotide.

21. The method of any one of claims 1, 2, 3 or 4 wherein the isolated DNA biobarcode is further amplified prior to the detecting step.

22. The method of claim 21 wherein the isolated DNA biobarcode is PCR amplified prior to the detecting step.

2. A method for detecting for the presence of one or more target analytes in a sample comprising:

providing one or more types of particle complex probes, each type of complex probe comprising a particle having oligonucleotides bound thereto, a DNA barcode, and a oligonucleotide having bound thereto a specific binding complement to a specific target analyte, wherein (i) the DNA barcode in each type of particle complex probe has a sequence that is different and that serves as an identifier for a particular target analyte;

(ii) the DNA barcode has a sequence having at least two portions;

(iii) at least some of the oligonucleotides attached to the particle have a sequence that is complementary to a first portion of the DNA barcode;

(iv) the oligonucleotides having bound thereto a specific binding complement have a sequence that is complementary to a second portion of the DNA barcode; and

wherein the DNA barcode in each type of particle complex probe is hybridized at least to some of the oligonucleotides attached to the particle and to the oligonucleotides having bound thereto the specific binding complement;

contacting the sample with a particle complex probe under conditions effective to allow specific binding interactions between the analyte and the particle complex probe and to form aggregated complexes in the presence of one or more analytes;

isolating the aggregated complexes and subjecting the aggregated complexes to conditions effective to dehybridize the aggregated complexes and to release the DNA barcodes;

isolating the DNA barcodes; and

detecting for the presence of one or more DNA barcodes having different sequences, wherein the identification of a particular DNA barcode is indicative of the presence of a specific target analyte in the sample.

3. A method for detecting for the presence of a target analyte in a sample comprising:

providing particles having oligonucleotides bound thereto, DNA barcodes, and oligonucleotides having bound thereto a specific binding complement to a target analyte, wherein the DNA barcodes have a sequence with at least two portions, at least some of the oligonucleotides attached to the particles have a sequence that is complementary to a first portion of the DNA barcodes, the oligonucleotides having bound thereto a specific binding complement have a sequence that is complementary to a second portion of the DNA barcodes;

contacting the particles having oligonucleotides bound thereto, the DNA barcodes, and the oligonucleotides having bound thereto a specific binding complement to a target analyte under conditions effective to allow the oligonucleotides bound to the particles, the DNA barcodes and the oligonucleotides having bound thereto the specific binding complement to the target analyte to form a particle complex probe;

isolating the particle complex probe;

contacting the sample with a particle complex probe under conditions effective to allow specific binding interactions between the analyte and the particle complex probe and form an aggregated complex in the presence of the analyte;

isolating the aggregated complex and subjecting the aggregated complex to conditions effective to dehybridize the aggregated complex and to release the DNA barcode;

isolating the DNA barcode; and

detecting for the presence of the DNA barcode, wherein the presence the DNA barcode is indicative of the presence of the target analyte in the sample.

4. A method for detecting for the presence of one or more target analytes in a sample comprising:

providing one or more types of particles having oligonucleotides bound thereto, one or more types of DNA barcodes, and one or more types of oligonucleotides having bound thereto a specific binding complement to a specific target analyte, wherein (i) the DNA barcode in each type of particle complex probe has a sequence that is different and that serves as an identifier for a particular target analyte;

(ii) each type of DNA barcode has a sequence having at least two portions;

(iii) at least some of the oligonucleotides attached to the particle have a sequence that is complementary to a first portion of one or more types of DNA barcodes;

(iv) each type of oligonucleotides having bound thereto a specific binding complement have a sequence that is complementary to a second portion of a type of DNA barcode; and

(v) each type of DNA barcode serves as an identifier for a particular target analyte and has a sequence that is different from another type of DNA barcode;

contacting the particles having oligonucleotides bound thereto, the DNA barcodes, and the oligonucleotides having bound thereto a specific binding complement to a target analyte under conditions effective to allow the oligonucleotides bound to the particles, the DNA barcodes and the oligonucleotides having bound thereto the specific binding complement to the target analyte to form a particle complex probe;

isolating the particle complex probes;

contacting the sample with a particle complex probe under conditions effective to allow specific binding interactions between the analyte and the particle complex probe and to form aggregated complexes in the presence of one or more analytes;

isolating the aggregated complexes and subjecting the aggregated complexes to conditions effective to dehybridize the aggregated complexes and to release the DNA barcodes;

isolating the DNA barcodes; and

detecting for the presence of one or more DNA barcodes having different sequences, wherein the identification of a particular DNA barcode is indicative of the presence of a specific target analyte.